0
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension

&
Pages 235-244 | Published online: 17 Sep 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dirk Bandilla, Marcel Goverde, Paolo Giudici & Olivier Lambert. (2017) Microbial challenge test of a novel epoprostenol sodium formulation. Drug Design, Development and Therapy 11, pages 2347-2357.
Read now

Articles from other publishers (10)

Nicola Di Trani, Fernanda P. Pons‐Faudoa, Antons Sizovs, Kathryn A. Shelton, Mark A. Marzinke, Pramod N. Nehete & Alessandro Grattoni. (2021) Extending Drug Release from Implants via Transcutaneous Refilling with Solid Therapeutics. Advanced Therapeutics 5:2, pages 2100214.
Crossref
Nicholas M. Furiasse & Jonathan D. Rich. 2016. Pulmonary Hypertension. Pulmonary Hypertension 257 270 .
Sarah L. Greig, Lesley J. Scott & Greg L. Plosker. (2014) Epoprostenol (Veletri®, Caripul®): A Review of Its Use in Patients with Pulmonary Arterial Hypertension. American Journal of Cardiovascular Drugs 14:6, pages 463-470.
Crossref
Rita Nogueira-Ferreira, Rita Ferreira & Tiago Henriques-Coelho. (2014) Cellular interplay in pulmonary arterial hypertension: Implications for new therapies. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843:5, pages 885-893.
Crossref
Olivier Sitbon, Marion Delcroix, Emmanuel Bergot, Anco B. Boonstra, John Granton, David Langleben, Pilar Escribano Subías, Nazzareno Galiè, Thomas Pfister, Jean-Christophe Lemarié & Gérald Simonneau. (2014) EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension. American Heart Journal 167:2, pages 210-217.
Crossref
Vallerie V. McLaughlin & Harold I. Palevsky. (2013) Parenteral and Inhaled Prostanoid Therapy in the Treatment of Pulmonary Arterial Hypertension. Clinics in Chest Medicine 34:4, pages 825-840.
Crossref
Yan Wu, Dermot S. O’Callaghan & Marc Humbert. (2013) An Update on Medical Therapy for Pulmonary Arterial Hypertension. Current Hypertension Reports 15:6, pages 614-622.
Crossref
Kimberly A Smith, Dustin R Fraidenburg & Jason X-J YuanBenton AshlockDavid Poch. 2013. Advances in The Management of Pulmonary Arterial Hypertension. Advances in The Management of Pulmonary Arterial Hypertension 52 63 .
Yuichi Tamura, Tomohiko Ono, Keiichi Fukuda, Toru Satoh & Shigetake Sasayama. (2013) Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4). Advances in Therapy 30:5, pages 459-471.
Crossref
Laurent B. Nicolas, Marcelo M. Gutierrez & Jasper Dingemanse. (2013) Comparative Pharmacokinetic, Pharmacodynamic, Safety, and Tolerability Profiles of 3 Different Formulations of Epoprostenol Sodium for Injection in Healthy Men. Clinical Therapeutics 35:4, pages 440-449.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.